Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock on a Bullish Journey, Here’s the Cause
Sonnet BioTherapeutics Holdings, Inc. (SONN), a clinical-stage biotechnology company focused on oncology, has gained an increase of 18.43 percentage points in the pre-market trading session. Consequently, the stock was trading at $0.61 when last checked. During Wednesday’s regular trading session, the stock rocketed by 86.73% to close the day at $0.52. The tremendous increase followed […]